L
LinusBio
Patient-centric precision exposome medicine, uncovering biomarkers and targets for diseases with historically limited molecular endpoints, spanning CNS, gastroenterology, renal disease, and oncology
About LinusBio
LinusBio is a pioneering startup that operates in the healthcare and biotechnology sector. The company has developed a unique platform that uses strands of hair to map the molecular dynamics of human physiology over time. This technology allows LinusBio to identify novel biomarkers—biological indicators that can signal the presence of health conditions or diseases.
The core of LinusBio's business is its temporal exposomic platform. "Exposomic" refers to the study of how environmental exposures affect human health. By analyzing hair samples, LinusBio can track how a person's biology responds to different environmental factors over time. This is akin to creating a timeline of an individual's health and environmental interactions.
LinusBio primarily serves healthcare providers, researchers, and pharmaceutical companies. These clients use the company's insights to improve patient care, advance scientific research, and develop new treatments. The market for LinusBio's services is vast, encompassing personalized medicine, public health, and environmental health sectors.
The company's business model revolves around providing detailed molecular analysis reports to its clients. These reports offer valuable insights that can be used for early disease detection, monitoring treatment efficacy, and understanding the impact of environmental factors on health. LinusBio generates revenue by charging for these analytical services and reports.
In summary, LinusBio stands at the intersection of biotechnology and data science, offering innovative solutions that reveal the intricate relationship between our environment and health. By leveraging cutting-edge technology, the company provides actionable insights that can lead to better health outcomes and more effective treatments.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2020
- Headquarters
- North Brunswick Township, United States
- Employees
- 30
- Open positions
- None listed
- Dealroom signal
- 62.9/100
- Industry
- Health
- Sub-industry
- Pharmaceutical, BioTechnology
- Sector
- Biotech & Life Sciences, Biotechnology, Drug Development, Spinout, Biotech and Pharma, Hard Tech, DT and LS, science-based
- Business model
- Manufacturing
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| LATE VC✓Equity / VC | Aug 2024 | $6.1M | $80M | Undisclosed | — |
| SERIES A✓Equity / VC | Jun 2023 | $8M | $80M | Bow Capital · David Bellet Family Office | ↗ |
Growth signals
Latest recorded traffic for LinusBio is 4.1K monthly website visits, up 141.2% over the last three months. LinusBio's team declined 14.3% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A5 investors entered at this stage
Bow Capital
GreatPoint Ventures
Sanford Robertson
Divergent Investments- DODavid Bellet Family Office
Other known investors1 additional known investor
- AKAshok Krishnamurthi
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about LinusBio on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See LinusBio’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.